Author:
Jabbour Elias,Paul Shilpa,Kantarjian Hagop
Publisher
Springer Science and Business Media LLC
Reference138 articles.
1. Ehrlich, P. Address in Pathology, on Chemotherapy: delivered before the Seventeenth International Congress of Medicine. Br. Med. J. 2, 353–359 (1913).
2. Di Gaetano, N. et al. Complement activation determines the therapeutic activity of rituximab in vivo. J. Immunol. 171, 1581–1587 (2003).
3. Taylor, R. P. & Lindorfer, M. A. The role of complement in mAb-based therapies of cancer. Methods 65, 18–27 (2014).
4. Mathe, G., Tran Ba, L. O. & Bernard, J. Effect on mouse leukemia 1210 of a combination by diazo-reaction of amethopterin and gamma-globulins from hamsters inoculated with such leukemia by heterografts. C. R. Hebd. Seances Acad. Sci. 246, 1626–1628 (1958).
5. Ghose, T., Cerini, M., Carter, M. & Nairn, R. C. Immunoradioactive agent against cancer. Br. Med. J. 1, 90–93 (1967).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献